| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 115.93M | — |
| Operating expense | — | — |
| Net income | -808.00K | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, IMCR returned +12.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +6.3% |
| 1 year | +12.0% |
| 5 years | +6.7% |
| All-time high | $72.29 (Jan 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in IMCR would be worth today ›No. Immunocore Holdings plc has not paid a dividend in the past 12 months.
Immunocore Holdings plc stock trades on NASDAQ under the ticker symbol IMCR.
Immunocore Holdings plc is part of the Healthcare sector.
Immunocore Holdings plc has a market cap of 1.90B USD, based on the latest quote.
Immunocore Holdings plc is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
